We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
We are a specialty CNS CRO that supports all phases of development for novel drugs. We provide scientific leadership and have extensive experience with the CNS approval process.
Our Scientific Leadership Team reviews every new protocol at the bid stage to assess the potential study risks, and works directly with the Sponsor as well as the CRO Project Teams to mitigate them in advance of FPI and then continues to be available throughout the life of the trial. Every Lotus Study is assigned a Scientific Leadership Team member from this list of Clinicians, Research Experts, and Scientists.
Lotus is a science-driven, full-service CRO with a number of unique qualities that no other CRO can provide. One particular differentiator is that we are under common ownership with Evolution Research Group (ERG), which is a clinical site organization with 20+ wholly-owned clinical research sites around the US.
Because of this connection to ERG, Lotus’ Sponsors benefit from one-stop shopping for:
Join us at ASCPT 2024 to Learn How Lotus Applies Better Science for Superior Results Lotus is gearing up for #ASCPT2024 in beautiful Colorado Springs from March
Placebo Response Mitigation in Pain Clinical Trials If you are attending the Pain Therapeutics Summit in San Diego then do not miss this exciting Pre-Conference
South Rampart Pharma Receives FDA Fast Track Designation NEW ORLEANS – South Rampart Pharma, a clinical-stage biopharmaceutical company targeting the safer treatment of pain, has
© 2025 Lotus Clinical Research, LLC. All Rights Reserved
